BENZALKONIUM CHLORIDE

BENZALKONIUM CHLORIDE was reported 439 times

BENZALKONIUM CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PARALYTIC GAIT 1 0.3333
1 SYNOVIAL FLUID ANALYSIS 13 0.1494
2 CONJUNCTIVAL SCAR 11 0.0728
3 KERATOUVEITIS 2 0.0541
4 RED BLOOD CELL SEDIMENTATION RATE DECREASED 11 0.0421
5 CONJUNCTIVAL GRANULOMA 1 0.0345
6 SYNOVIAL DISORDER 13 0.0286
7 ACANTHAMOEBA KERATITIS 1 0.0270
8 TENOSYNOVITIS STENOSANS 13 0.0233
9 CATARACT TRAUMATIC 1 0.0233
10 HEPATIC ENZYME DECREASED 10 0.0223
11 GASTROINTESTINAL TOXICITY 107 0.0222
12 SECOND DEGREE CHEMICAL BURN OF SKIN 1 0.0167
13 WRONG PRODUCT PROCURED 1 0.0152
14 C-REACTIVE PROTEIN ABNORMAL 97 0.0151
15 PULMONARY TOXICITY 106 0.0150
16 GALLBLADDER ADENOCARCINOMA 1 0.0141
17 TOXIC ANTERIOR SEGMENT SYNDROME 15 0.0137
18 VAGINAL FLATULENCE 4 0.0132
19 ALLERGY TO CHEMICALS 15 0.0120
20 PROSTHESIS USER 1 0.0111
21 CHEST EXPANSION DECREASED 1 0.0108
22 CHEMICAL EYE INJURY 1 0.0102
23 APPLICATION SITE NECROSIS 1 0.0097
24 PROPIONIBACTERIUM INFECTION 1 0.0093
25 BONE TRIMMING 1 0.0088
26 KERATIC PRECIPITATES 4 0.0084
27 OLIGODENDROGLIOMA 1 0.0083
28 SCLERITIS 13 0.0081
29 CORNEAL NEOVASCULARISATION 2 0.0081
30 CONJUNCTIVAL IRRITATION 1 0.0074
31 NASAL FLARING 1 0.0074
32 PRIMARY HYPERALDOSTERONISM 1 0.0064
33 EYE PARAESTHESIA 1 0.0064
34 APPLICATION SITE WOUND 1 0.0061
35 LARYNGEAL INJURY 1 0.0058
36 MICROSPORIDIA INFECTION 2 0.0057
37 GRANULOCYTOSIS 1 0.0051
38 JOINT INJURY 106 0.0050
39 HEPATOTOXICITY 108 0.0048
40 RHEUMATOID NODULE 13 0.0047
41 TENOSYNOVITIS 13 0.0047
42 PLEURITIC PAIN 13 0.0047
43 MEIBOMIAN GLAND DYSFUNCTION 2 0.0044
44 GRIP STRENGTH 1 0.0044
45 CREPITATIONS 13 0.0044
46 CUSHINGOID 14 0.0044
47 STATUS ASTHMATICUS 2 0.0042
48 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 1 0.0042
49 ANTINUCLEAR ANTIBODY POSITIVE 13 0.0040
50 REACTION TO PRESERVATIVES 3 0.0037
51 ENTEROCOLITIS BACTERIAL 1 0.0036
52 DAIRY INTOLERANCE 1 0.0036
53 JOINT STIFFNESS 93 0.0035
54 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1 0.0035
55 CHEMICAL BURN 4 0.0035
56 CELLULITIS ORBITAL 2 0.0034
57 FACET JOINT SYNDROME 11 0.0034
58 BRONCHOSPASM PARADOXICAL 1 0.0033
59 CATARACT SUBCAPSULAR 2 0.0033
60 CONTRAINDICATED DEVICE USED 1 0.0031
61 TACHYPHYLAXIS 1 0.0029
62 RADIAL NERVE PALSY 1 0.0028
63 SYNOVIAL CYST 13 0.0028
64 GLOBULINS INCREASED 1 0.0027
65 BOVINE TUBERCULOSIS 1 0.0026
66 REACTION TO EXCIPIENT 6 0.0026
67 THERAPY NON-RESPONDER 113 0.0025
68 USE OF ACCESSORY RESPIRATORY MUSCLES 1 0.0024
69 ARTERIAL THROMBOSIS LIMB 1 0.0024
70 HAEMOGLOBIN INCREASED 11 0.0024
71 LUPUS VULGARIS 3 0.0024
72 FEMALE GENITAL TRACT FISTULA 4 0.0023
73 PEAK EXPIRATORY FLOW RATE DECREASED 1 0.0023
74 SEXUAL ABUSE 1 0.0023
75 POST THROMBOTIC SYNDROME 1 0.0022
76 LACRIMATION DECREASED 1 0.0021
77 MUSCULOSKELETAL PAIN 109 0.0021
78 BONE DEBRIDEMENT 1 0.0021
79 INTRAOCULAR LENS IMPLANT 1 0.0020
80 JOINT EFFUSION 13 0.0019
81 EYE INFECTION BACTERIAL 1 0.0018
82 NAIL DYSTROPHY 1 0.0018
83 ARTHROPATHY 98 0.0018
84 CORNEAL EPITHELIUM DEFECT 1 0.0017
85 PRODUCT CONTAMINATION MICROBIAL 2 0.0017
86 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
87 NEOPLASM MALIGNANT 108 0.0016
88 CHALAZION 1 0.0016
89 NODULAR REGENERATIVE HYPERPLASIA 1 0.0016
90 C-REACTIVE PROTEIN DECREASED 1 0.0015
91 RADICULOPATHY 4 0.0015
92 LYMPHOCELE 1 0.0015
93 DUODENAL ULCER PERFORATION 11 0.0015
94 RETINAL PIGMENT EPITHELIAL TEAR 1 0.0014
95 FOLLICULITIS 15 0.0014
96 PROCTITIS 4 0.0014
97 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 101 0.0014
98 DEFORMITY 13 0.0014
99 FLANK PAIN 13 0.0014
100 INFANTILE SPASMS 1 0.0014
101 STOMA SITE PAIN 2 0.0014
102 ATELECTASIS 13 0.0013
103 LYMPH NODE TUBERCULOSIS 1 0.0013
104 ASEPTIC NECROSIS BONE 1 0.0013
105 TREATMENT FAILURE 105 0.0013
106 MUSCULOSKELETAL STIFFNESS 111 0.0013
107 TENDERNESS 13 0.0012
108 BLEPHARITIS 5 0.0012
109 SKIN BACTERIAL INFECTION 1 0.0012
110 ABDOMINAL SYMPTOM 1 0.0012
111 CHEMICAL INJURY 1 0.0012
112 CONTRAINDICATED PRODUCT ADMINISTERED 37 0.0012
113 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
114 LIP PRURITUS 1 0.0012
115 HELICOBACTER INFECTION 12 0.0012
116 BURSITIS 14 0.0012
117 BLOOD ALBUMIN INCREASED 1 0.0011
118 NODULE 14 0.0011
119 APPLICATION SITE DERMATITIS 1 0.0011
120 STOMA SITE ERYTHEMA 2 0.0011
121 HAND DEFORMITY 14 0.0011
122 CHRONIC SINUSITIS 4 0.0011
123 INTUSSUSCEPTION 1 0.0010
124 QUALITY OF LIFE DECREASED 14 0.0010
125 NEUROENDOCRINE CARCINOMA OF THE SKIN 1 0.0010
126 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
127 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
128 ONYCHALGIA 1 0.0010
129 DRUG INTOLERANCE 94 0.0010
130 JOINT RANGE OF MOTION DECREASED 13 0.0010
131 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 2 0.0010
132 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 1 0.0009
133 PNEUMONIA STREPTOCOCCAL 1 0.0009
134 JOINT SWELLING 109 0.0009
135 SUBCLAVIAN VEIN THROMBOSIS 1 0.0009
136 DISLOCATION OF VERTEBRA 2 0.0009
137 OPTIC NERVE INJURY 1 0.0009
138 ISCHAEMIC CEREBRAL INFARCTION 1 0.0009
139 THERAPEUTIC PRODUCT EFFECT DECREASED 38 0.0008
140 MONOCYTE COUNT DECREASED 1 0.0008
141 ULCER 13 0.0008
142 HAEMATOCRIT ABNORMAL 1 0.0008
143 BLADDER DISCOMFORT 1 0.0008
144 OVARIAN CYST RUPTURED 1 0.0008
145 IMMUNE RECONSTITUTION SYNDROME 1 0.0008
146 RETINAL DEGENERATION 1 0.0008
147 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 1 0.0008
148 INFECTION 110 0.0008
149 TUMOUR PAIN 1 0.0008
150 CONJUNCTIVITIS 14 0.0008
151 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
152 RHINALGIA 2 0.0007
153 TOXIC EPIDERMAL NECROLYSIS 11 0.0007
154 MENINGITIS BACTERIAL 1 0.0007
155 PORPHYRIA ACUTE 1 0.0007
156 INFLAMMATION 36 0.0007
157 PHOTOPHOBIA 13 0.0007
158 FEELING JITTERY 13 0.0007
159 CONJUNCTIVITIS ALLERGIC 1 0.0007
160 SMALL CELL LUNG CANCER 1 0.0007
161 KERATITIS 2 0.0007
162 SKIN ULCER 17 0.0007
163 VASCULAR RUPTURE 1 0.0006
164 SCIATICA 10 0.0006
165 FIBROMYALGIA 15 0.0006
166 OPTIC ATROPHY 1 0.0006
167 IMPAIRED WORK ABILITY 13 0.0006
168 MUSCLE INJURY 5 0.0006
169 GLIOBLASTOMA 1 0.0006
170 RASH MACULO-PAPULAR 13 0.0006
171 BLOOD AMYLASE INCREASED 1 0.0006
172 PRODUCT PREPARATION ERROR 12 0.0006
173 RETINITIS 1 0.0006
174 INFUSION SITE DISCHARGE 1 0.0006
175 PANCREATIC FAILURE 1 0.0006
176 BONE EROSION 2 0.0006
177 SKIN WEEPING 2 0.0006
178 LIVER TRANSPLANT REJECTION 1 0.0006
179 VENOUS OCCLUSION 1 0.0005
180 OCULAR HYPERAEMIA 26 0.0005
181 LOBAR PNEUMONIA 1 0.0005
182 PURULENCE 1 0.0005
183 HYPERAEMIA 1 0.0005
184 MACULAR DEGENERATION 6 0.0005
185 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
186 VAGINAL DISCHARGE 5 0.0005
187 RENAL HAEMORRHAGE 1 0.0005
188 GLOSSODYNIA 11 0.0005
189 RHEUMATOID ARTHRITIS 53 0.0005
190 JAW FRACTURE 1 0.0005
191 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3 0.0005
192 CERVICAL DYSPLASIA 1 0.0005
193 CORNEAL DISORDER 1 0.0005
194 RED BLOOD CELL COUNT DECREASED 13 0.0005
195 PRODUCT FORMULATION ISSUE 3 0.0005
196 CORNEAL OEDEMA 1 0.0004
197 PRODUCT LABEL ISSUE 3 0.0004
198 EYELID DISORDER 1 0.0004
199 APHTHOUS STOMATITIS 1 0.0004
200 LICHEN PLANUS 1 0.0004
201 PRURITUS GENITAL 1 0.0004
202 VARICELLA 1 0.0004
203 BONE DENSITY DECREASED 13 0.0004
204 STILLBIRTH 2 0.0004
205 LYMPHADENITIS 1 0.0004
206 APPLICATION SITE BURN 2 0.0004
207 IMPAIRED HEALING 13 0.0004
208 CHEMICAL BURN OF SKIN 1 0.0004
209 BLOOD CHLORIDE DECREASED 1 0.0004
210 C-REACTIVE PROTEIN INCREASED 14 0.0004
211 PAIN IN EXTREMITY 113 0.0004
212 EYE IRRITATION 22 0.0004
213 ORAL CANDIDIASIS 5 0.0004
214 CONDITION AGGRAVATED 115 0.0004
215 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
216 COMPRESSION FRACTURE 2 0.0004
217 ULCERATIVE KERATITIS 1 0.0004
218 THERAPEUTIC RESPONSE DELAYED 1 0.0004
219 TYPE 2 DIABETES MELLITUS 12 0.0004
220 DRUG TOLERANCE DECREASED 1 0.0004
221 RETINAL VEIN OCCLUSION 1 0.0003
222 HYPERVENTILATION 2 0.0003
223 PRODUCT LABEL CONFUSION 2 0.0003
224 ABORTION 1 0.0003
225 PULMONARY PAIN 1 0.0003
226 DRY EYE 17 0.0003
227 LIVER DISORDER 15 0.0003
228 HYPERCAPNIA 1 0.0003
229 INTERSTITIAL LUNG DISEASE 16 0.0003
230 EYE INJURY 1 0.0003
231 IRITIS 1 0.0003
232 EXOSTOSIS 3 0.0003
233 MEDICAL DEVICE DISCOMFORT 1 0.0003
234 APPLICATION SITE IRRITATION 4 0.0003
235 INJECTION SITE HYPERSENSITIVITY 1 0.0003
236 EYE PAIN 18 0.0003
237 HYPERCHOLESTEROLAEMIA 3 0.0003
238 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
239 BREAST CANCER STAGE III 2 0.0003
240 POSTURE ABNORMAL 1 0.0003
241 THROMBOSIS IN DEVICE 1 0.0003
242 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
243 SKIN INJURY 1 0.0003
244 OVARIAN CYST 3 0.0003
245 APPLICATION SITE DRYNESS 1 0.0003
246 PRODUCT ODOUR ABNORMAL 3 0.0003
247 CONJUNCTIVAL HYPERAEMIA 1 0.0003
248 PERIPHERAL SWELLING 43 0.0003
249 ARTHRALGIA 116 0.0003
250 PARAESTHESIA ORAL 4 0.0003
251 RASH PRURITIC 15 0.0003
252 ASTHMATIC CRISIS 1 0.0003
253 BLINDNESS TRANSIENT 2 0.0003
254 FOOT DEFORMITY 3 0.0003
255 WHEEZING 16 0.0003
256 LUNG DISORDER 13 0.0003
257 DERMATITIS CONTACT 3 0.0003
258 OESOPHAGEAL ULCER 1 0.0003
259 OESOPHAGEAL DISORDER 1 0.0003
260 PROCEDURAL HAEMORRHAGE 1 0.0003
261 MEDICATION ERROR 14 0.0003
262 PERIPHERAL VENOUS DISEASE 1 0.0002
263 PERIPHERAL ISCHAEMIA 1 0.0002
264 INFUSION RELATED REACTION 16 0.0002
265 ROAD TRAFFIC ACCIDENT 10 0.0002
266 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
267 PSEUDOMONAS INFECTION 2 0.0002
268 PAPILLOEDEMA 1 0.0002
269 APPLICATION SITE RASH 3 0.0002
270 RESPIRATORY DISTRESS 6 0.0002
271 ROSACEA 1 0.0002
272 SKIN ABRASION 1 0.0002
273 SARCOIDOSIS 1 0.0002
274 BRONCHOSPASM 3 0.0002
275 NON-SMALL CELL LUNG CANCER 1 0.0002
276 KIDNEY TRANSPLANT REJECTION 1 0.0002
277 VENOOCCLUSIVE LIVER DISEASE 1 0.0002
278 APPLICATION SITE SWELLING 1 0.0002
279 SWELLING FACE 13 0.0002
280 PHLEBITIS 1 0.0002
281 EYE DISCHARGE 2 0.0002
282 SWELLING 18 0.0002
283 EAR INFECTION 5 0.0002
284 IRRITABLE BOWEL SYNDROME 4 0.0002
285 INJECTION SITE DISCHARGE 1 0.0002
286 FREQUENT BOWEL MOVEMENTS 5 0.0002
287 HIP SURGERY 1 0.0002
288 DEAFNESS UNILATERAL 1 0.0002
289 CYSTIC FIBROSIS 1 0.0002
290 COLITIS ULCERATIVE 8 0.0002
291 ARTHRITIS 14 0.0002
292 THROMBOSIS 14 0.0002
293 DRY MOUTH 14 0.0002
294 URINE ODOUR ABNORMAL 1 0.0002
295 PLEURISY 1 0.0002
296 HEARING IMPAIRED 1 0.0002
297 HEPATITIS CHOLESTATIC 1 0.0002
298 VULVOVAGINAL BURNING SENSATION 1 0.0002
299 SCOLIOSIS 1 0.0002
300 BLISTER 9 0.0002
301 PEMPHIGUS 2 0.0002
302 HEPATIC CIRRHOSIS 3 0.0002
303 WHITE BLOOD CELL COUNT DECREASED 17 0.0002
304 ENTERITIS 1 0.0002
305 SINUSITIS 16 0.0002
306 MYDRIASIS 2 0.0002
307 GLAUCOMA 3 0.0002
308 HAEMOGLOBIN ABNORMAL 1 0.0002
309 POOR QUALITY DRUG ADMINISTERED 1 0.0002
310 APPLICATION SITE VESICLES 1 0.0002
311 ASPERGILLUS INFECTION 1 0.0002
312 EYE HAEMORRHAGE 2 0.0001
313 WRONG PRODUCT ADMINISTERED 1 0.0001
314 ULCER HAEMORRHAGE 1 0.0001
315 PROCEDURAL PAIN 4 0.0001
316 ORAL DISCOMFORT 2 0.0001
317 PAPULE 1 0.0001
318 RETINAL HAEMORRHAGE 1 0.0001
319 GRAFT VERSUS HOST DISEASE 1 0.0001
320 DERMATITIS BULLOUS 1 0.0001
321 HYPOKINESIA 2 0.0001
322 VISUAL IMPAIRMENT 17 0.0001
323 MAJOR DEPRESSION 1 0.0001
324 HAEMOGLOBIN DECREASED 14 0.0001
325 STEVENS-JOHNSON SYNDROME 3 0.0001
326 FEELING DRUNK 1 0.0001
327 LACRIMATION INCREASED 4 0.0001
328 STOMATITIS 8 0.0001
329 COLITIS 5 0.0001
330 FOOD ALLERGY 1 0.0001
331 ATRIOVENTRICULAR BLOCK 1 0.0001
332 CONCUSSION 1 0.0001
333 APHTHOUS ULCER 1 0.0001
334 SLEEP DISORDER 9 0.0001
335 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
336 NASAL DISCOMFORT 1 0.0001
337 RASH ERYTHEMATOUS 6 0.0001
338 RHINITIS 1 0.0001
339 SHOCK HAEMORRHAGIC 1 0.0001
340 ESCHERICHIA INFECTION 1 0.0001
341 HAEMODIALYSIS 1 0.0001
342 PERICARDITIS 2 0.0001
343 EYE PRURITUS 4 0.0001
344 INFUSION SITE ERYTHEMA 1 0.0001
345 RECTAL HAEMORRHAGE 5 0.0001
346 PYELONEPHRITIS 1 0.0001
347 DELIRIUM 4 0.0001
348 MUSCULAR WEAKNESS 13 0.0001
349 METASTASES TO LIVER 2 0.0001
350 GRIP STRENGTH DECREASED 1 0.0001
351 GASTROINTESTINAL INFECTION 1 0.0001
352 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
353 SKIN DISCOLOURATION 5 0.0001
354 ERYTHEMA MULTIFORME 1 0.0001
355 ARTERIOSCLEROSIS 1 0.0001
356 LOWER LIMB FRACTURE 2 0.0001
357 ACUTE RESPIRATORY FAILURE 2 0.0001
358 PRESCRIBED OVERDOSE 2 0.0001
359 AUTOIMMUNE DISORDER 1 0.0001
360 ERYTHEMA 21 0.0001
361 KNEE OPERATION 1 0.0001
362 HYPOTHERMIA 1 0.0001
363 EYELID PTOSIS 1 0.0001
364 DRUG INEFFECTIVE 128 0.0001
365 WEIGHT FLUCTUATION 1 0.0001
366 TRANSFUSION 1 0.0001
367 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
368 JOINT DISLOCATION 1 0.0001
369 BODY HEIGHT DECREASED 1 0.0001
370 TOOTH DISORDER 2 0.0001
371 HYPOAESTHESIA 13 0.0001
372 EYELID OEDEMA 1 0.0001
373 ABDOMINAL PAIN 20 0.0001
374 COVID-19 PNEUMONIA 1 0.0001
375 ADRENAL INSUFFICIENCY 1 0.0001
376 MYALGIA 14 0.0001
377 BACK PAIN 19 0.0001
378 INJECTION SITE URTICARIA 2 0.0001
379 HYPERSENSITIVITY 15 0.0001
380 EYE SWELLING 3 0.0001
381 ILEUS 1 0.0001
382 TOOTH EXTRACTION 1 0.0001
383 INJECTION SITE DISCOLOURATION 1 0.0001
384 BRAIN OEDEMA 1 0.0001
385 PRODUCT COMPLAINT 2 0.0001
386 INFUSION SITE PAIN 1 0.0001
387 APPLICATION SITE ERYTHEMA 2 0.0001
388 DYSMENORRHOEA 1 0.0001
389 MALIGNANT MELANOMA 1 0.0001
390 BLINDNESS 3 0.0001
391 PNEUMONITIS 2 0.0001
392 PERIPHERAL COLDNESS 1 0.0001
393 RESPIRATORY ARREST 2 0.0001
394 HAEMATOCHEZIA 4 0.0001
395 HUNGER 1 0.0001
396 DEVICE OCCLUSION 1 0.0001
397 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
398 HYPERTENSION 15 0.0001
399 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
400 CARDIOGENIC SHOCK 1 0.0001
401 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
402 LABORATORY TEST ABNORMAL 2 0.0001
403 HAEMORRHAGE INTRACRANIAL 1 0.0001
404 PYREXIA 23 0.0001
405 LIMB DISCOMFORT 2 0.0001
406 LUNG INFECTION 1 0.0001
407 ACUTE MYELOID LEUKAEMIA 1 0.0001
408 BASAL CELL CARCINOMA 1 0.0001
409 DRUG-INDUCED LIVER INJURY 2 0.0001
410 PRODUCT USE COMPLAINT 1 0.0001
411 SICKLE CELL ANAEMIA WITH CRISIS 1 0.0001
412 OBESITY 1 0.0001
413 ABSCESS 1 0.0001
414 FEELING ABNORMAL 15 0.0001
415 NIGHT SWEATS 2 0.0001
416 RASH 27 0.0001
417 METASTASES TO BONE 1 0.0001
418 WEIGHT DECREASED 17 0.0001
419 EYE DISORDER 2 0.0001
420 STAPHYLOCOCCAL INFECTION 2 0.0001
421 CARDIAC ARREST 5 0.0001
422 PHOTOSENSITIVITY REACTION 1 0.0001
423 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
424 PAIN 37 0.0001
425 VISUAL ACUITY REDUCED 2 0.0001
426 CYTOMEGALOVIRUS INFECTION 1 0.0001
427 COAGULOPATHY 1 0.0001
428 SKIN DISORDER 2 0.0001
429 GAIT INABILITY 2 0.0001
430 BLOOD UREA INCREASED 1 0.0001
431 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
432 CANDIDA INFECTION 1 0.0001
433 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
434 METRORRHAGIA 1 0.0001
435 HOSPITALISATION 9 0.0001
436 ANAEMIA 11 0.0001
437 HYPOXIA 2 0.0001
438 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
439 DRUG ERUPTION 1 0.0001
440 ISCHAEMIC STROKE 1 0.0001
441 CEREBRAL HAEMORRHAGE 2 0.0001
442 GASTROINTESTINAL DISORDER 5 0.0001
443 SYNOVITIS 1 0.0001
444 GASTROENTERITIS VIRAL 1 0.0001
445 OSTEOMYELITIS 1 0.0001
446 OFF LABEL USE 47 0.0001
447 BLOOD SODIUM DECREASED 1 0.0001
448 GASTRIC ULCER 1 0.0001
449 NEUROPATHY PERIPHERAL 5 0.0001
450 PULMONARY FIBROSIS 1 0.0001
451 DYSTONIA 1 0.0001
452 EAR PAIN 1 0.0001
453 CHOKING 1 0.0001
454 SKIN FISSURES 1 0.0001
455 MENORRHAGIA 1 0.0001
456 DYSPEPSIA 5 0.0001
457 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
458 CATARACT 3 0.0001
459 MALAISE 22 0.0001
460 INJECTION SITE BRUISING 4 0.0001
461 PRESCRIBED UNDERDOSE 1 0.0001
462 DYSPNOEA 28 0.0000
463 PRURITUS 19 0.0000
464 ILL-DEFINED DISORDER 3 0.0000
465 EXTRA DOSE ADMINISTERED 2 0.0000
466 BONE MARROW FAILURE 1 0.0000
467 BODY TEMPERATURE INCREASED 1 0.0000
468 FEELING HOT 3 0.0000
469 LUNG NEOPLASM MALIGNANT 2 0.0000
470 DERMATITIS 1 0.0000
471 RENAL FAILURE ACUTE 2 0.0000
472 PNEUMONIA 15 0.0000
473 AMNESIA 3 0.0000
474 MELAENA 1 0.0000
475 APPLICATION SITE PAIN 1 0.0000
476 PANCREATITIS ACUTE 1 0.0000
477 APPLICATION SITE PRURITUS 1 0.0000
478 PERICARDIAL EFFUSION 1 0.0000
479 BURNING SENSATION 3 0.0000
480 DISEASE RECURRENCE 2 0.0000
481 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
482 RESPIRATORY FAILURE 3 0.0000
483 LIVER INJURY 1 0.0000
484 BRONCHITIS 3 0.0000
485 PNEUMONIA ASPIRATION 1 0.0000
486 LEUKOPENIA 2 0.0000
487 UNEVALUABLE EVENT 3 0.0000
488 HAEMATEMESIS 1 0.0000
489 INJECTION SITE SWELLING 3 0.0000
490 ILLNESS 4 0.0000
491 ANAPHYLACTIC SHOCK 1 0.0000
492 UNRESPONSIVE TO STIMULI 1 0.0000
493 HAEMATOMA 1 0.0000
494 ECZEMA 2 0.0000
495 MUCOSAL INFLAMMATION 1 0.0000
496 GASTRITIS 1 0.0000
497 CHEST PAIN 7 0.0000
498 INJECTION SITE HAEMORRHAGE 3 0.0000
499 JAUNDICE 1 0.0000
500 CONFUSIONAL STATE 6 0.0000
501 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
502 DIVERTICULITIS 1 0.0000
503 SKIN EXFOLIATION 3 0.0000
504 ASTHMA 4 0.0000
505 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
506 HERPES ZOSTER 2 0.0000
507 PRODUCT SUBSTITUTION ISSUE 2 0.0000
508 FATIGUE 27 0.0000
509 SEIZURE 4 0.0000
510 DYSSTASIA 1 0.0000
511 BONE PAIN 2 0.0000
512 DIZZINESS 17 0.0000
513 DIARRHOEA 22 0.0000
514 ASCITES 1 0.0000
515 RESPIRATORY DISORDER 1 0.0000
516 BLOOD POTASSIUM DECREASED 1 0.0000
517 NAUSEA 26 0.0000
518 DISCOMFORT 2 0.0000
519 DRUG ADMINISTRATION ERROR 1 0.0000
520 ADVERSE EVENT 3 0.0000
521 NASOPHARYNGITIS 6 0.0000
522 HEAD INJURY 1 0.0000
523 HYPOTHYROIDISM 1 0.0000
524 CONTUSION 3 0.0000
525 RHINORRHOEA 2 0.0000
526 DEEP VEIN THROMBOSIS 2 0.0000
527 BLOOD CREATININE INCREASED 2 0.0000
528 FEBRILE NEUTROPENIA 2 0.0000
529 LIP SWELLING 1 0.0000
530 URINARY RETENTION 1 0.0000
531 INJECTION SITE PRURITUS 2 0.0000
532 TOXICITY TO VARIOUS AGENTS 5 0.0000
533 FLUSHING 3 0.0000
534 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
535 CHEST DISCOMFORT 3 0.0000
536 HAEMATURIA 1 0.0000
537 MEMORY IMPAIRMENT 4 0.0000
538 RASH MACULAR 1 0.0000
539 INJURY 2 0.0000
540 PLATELET COUNT DECREASED 3 0.0000
541 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
542 ACCIDENTAL OVERDOSE 1 0.0000
543 RESTLESSNESS 1 0.0000
544 HEPATIC FUNCTION ABNORMAL 1 0.0000
545 WEIGHT INCREASED 6 0.0000
546 EPISTAXIS 2 0.0000
547 HALLUCINATION 2 0.0000
548 CHRONIC KIDNEY DISEASE 2 0.0000
549 CHILLS 3 0.0000
550 CARDIAC FAILURE 2 0.0000
551 PSORIATIC ARTHROPATHY 1 0.0000
552 OSTEOPOROSIS 1 0.0000
553 ABDOMINAL PAIN UPPER 5 0.0000
554 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
555 OSTEOARTHRITIS 1 0.0000
556 URINARY TRACT INFECTION 4 0.0000
557 HYPOACUSIS 1 0.0000
558 DEVICE LEAKAGE 1 0.0000
559 SEPTIC SHOCK 1 0.0000
560 MENTAL DISORDER 1 0.0000
561 CONSTIPATION 5 0.0000
562 INTENTIONAL PRODUCT MISUSE 2 0.0000
563 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
564 COVID-19 4 0.0000
565 RENAL FAILURE 3 0.0000
566 TACHYCARDIA 2 0.0000
567 DEHYDRATION 3 0.0000
568 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
569 HEADACHE 14 0.0000
570 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
571 THROAT IRRITATION 1 0.0000
572 VISION BLURRED 3 0.0000
573 SKIN IRRITATION 1 0.0000
574 OROPHARYNGEAL PAIN 2 0.0000
575 RENAL DISORDER 1 0.0000
576 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
577 DYSPHAGIA 2 0.0000
578 PULMONARY EMBOLISM 2 0.0000
579 MIGRAINE 2 0.0000
580 COLORECTAL CANCER 1 0.0000
581 PRODUCTIVE COUGH 1 0.0000
582 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
583 NERVOUSNESS 1 0.0000
584 SPEECH DISORDER 1 0.0000
585 DERMATITIS ATOPIC 1 0.0000
586 PANCREATITIS 1 0.0000
587 BRADYCARDIA 1 0.0000
588 DRUG EFFECT DECREASED 1 0.0000
589 TREATMENT NONCOMPLIANCE 1 0.0000
590 ANAPHYLACTIC REACTION 1 0.0000
591 URTICARIA 3 0.0000
592 PANCYTOPENIA 1 0.0000
593 COUGH 5 0.0000
594 LETHARGY 1 0.0000
595 DECREASED APPETITE 4 0.0000
596 DYSPHONIA 1 0.0000
597 SURGERY 1 0.0000
598 NASAL CONGESTION 1 0.0000
599 BLADDER CANCER 1 0.0000
600 IRRITABILITY 1 0.0000
601 THERAPEUTIC RESPONSE DECREASED 1 0.0000
602 PLEURAL EFFUSION 1 0.0000
603 EXPOSURE DURING PREGNANCY 1 0.0000
604 PRODUCT USE ISSUE 3 0.0000
605 ASTHENIA 6 0.0000
606 GAIT DISTURBANCE 3 0.0000
607 LOSS OF CONSCIOUSNESS 2 0.0000
608 DEVICE EXPULSION 1 0.0000
609 ALOPECIA 3 0.0000
610 DEVICE DIFFICULT TO USE 1 0.0000
611 BLOOD PRESSURE DECREASED 1 0.0000
612 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
613 INJECTION SITE REACTION 1 0.0000
614 ANXIETY 4 0.0000
615 SKIN BURNING SENSATION 1 0.0000
616 MOBILITY DECREASED 1 0.0000
617 UNDERDOSE 1 0.0000
618 PRODUCT DOSE OMISSION ISSUE 4 0.0000
619 DYSGEUSIA 1 0.0000
620 HOT FLUSH 1 0.0000
621 DEPRESSION 3 0.0000
622 VOMITING 6 0.0000
623 PARAESTHESIA 2 0.0000
624 DRUG INTERACTION 2 0.0000
625 CARDIAC FAILURE CONGESTIVE 1 0.0000
626 PROSTATE CANCER 1 0.0000
627 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
628 INFLUENZA LIKE ILLNESS 1 0.0000
629 TREMOR 2 0.0000
630 ABDOMINAL DISCOMFORT 2 0.0000
631 PRODUCT STORAGE ERROR 1 0.0000
632 INSOMNIA 3 0.0000
633 ADVERSE DRUG REACTION 1 0.0000
634 SUICIDAL IDEATION 1 0.0000
635 MUSCLE SPASMS 2 0.0000
636 BREAST CANCER 1 0.0000
637 CARDIAC DISORDER 1 0.0000
638 BLOOD GLUCOSE INCREASED 2 0.0000
639 ATRIAL FIBRILLATION 1 0.0000
640 INJECTION SITE PAIN 3 0.0000
641 ABDOMINAL DISTENSION 1 0.0000
642 OVERDOSE 2 0.0000
643 INFLUENZA 1 0.0000
644 SEPSIS 1 0.0000
645 EMOTIONAL DISTRESS 1 0.0000
646 INJECTION SITE ERYTHEMA 1 0.0000
647 PSORIASIS 1 0.0000
648 DRY SKIN 1 0.0000
649 PRODUCT QUALITY ISSUE 1 0.0000
650 ACUTE KIDNEY INJURY 1 0.0000
651 FALL 2 0.0000
652 CEREBROVASCULAR ACCIDENT 1 0.0000
653 MYOCARDIAL INFARCTION 1 0.0000
654 NO ADVERSE EVENT 1 0.0000
655 HYPOTENSION 1 0.0000
656 SOMNOLENCE 1 0.0000
657 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
658 DEATH 4 0.0000